Commonwealth Equity Services’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.77M | Buy |
14,101
+390
| +3% | +$49K | ﹤0.01% | 2082 |
|
|
2025
Q1 | $1.52M | Sell |
13,711
-245
| -2% | -$27.1K | ﹤0.01% | 2131 |
|
|
2024
Q4 | $1.91M | Sell |
13,956
-1,320
| -9% | -$180K | ﹤0.01% | 1904 |
|
|
2024
Q3 | $1.76M | Buy |
15,276
+360
| +2% | +$41.5K | ﹤0.01% | 1897 |
|
|
2024
Q2 | $2.05M | Buy |
14,916
+975
| +7% | +$134K | ﹤0.01% | 1770 |
|
|
2024
Q1 | $1.92M | Buy |
13,941
+84
| +0.6% | +$11.6K | ﹤0.01% | 1816 |
|
|
2023
Q4 | $1.83M | Sell |
13,857
-150
| -1% | -$19.8K | ﹤0.01% | 1758 |
|
|
2023
Q3 | $1.58M | Sell |
14,007
-1,097
| -7% | -$123K | ﹤0.01% | 1769 |
|
|
2023
Q2 | $1.42M | Sell |
15,104
-234
| -2% | -$22.1K | ﹤0.01% | 1858 |
|
|
2023
Q1 | $1.55K | Buy |
15,338
+200
| +1% | +$20 | ﹤0.01% | 1726 |
|
|
2022
Q4 | $1.81M | Buy |
15,138
+440
| +3% | +$52.6K | ﹤0.01% | 1563 |
|
|
2022
Q3 | $1.56M | Sell |
14,698
-1,809
| -11% | -$192K | ﹤0.01% | 1593 |
|
|
2022
Q2 | $1.61M | Sell |
16,507
-2,138
| -11% | -$208K | ﹤0.01% | 1564 |
|
|
2022
Q1 | $1.75M | Buy |
18,645
+182
| +1% | +$17.1K | ﹤0.01% | 1589 |
|
|
2021
Q4 | $1.57M | Sell |
18,463
-342
| -2% | -$29.1K | ﹤0.01% | 1659 |
|
|
2021
Q3 | $1.8M | Sell |
18,805
-1,375
| -7% | -$132K | ﹤0.01% | 1494 |
|
|
2021
Q2 | $1.96M | Buy |
20,180
+537
| +3% | +$52.2K | 0.01% | 1426 |
|
|
2021
Q1 | $1.91M | Sell |
19,643
-1,221
| -6% | -$119K | 0.01% | 1348 |
|
|
2020
Q4 | $2M | Sell |
20,864
-3,278
| -14% | -$314K | 0.01% | 1231 |
|
|
2020
Q3 | $2.32M | Buy |
24,142
+217
| +0.9% | +$20.9K | 0.01% | 1011 |
|
|
2020
Q2 | $2.92M | Buy |
23,925
+705
| +3% | +$86K | 0.01% | 831 |
|
|
2020
Q1 | $2.01M | Buy |
23,220
+265
| +1% | +$22.9K | 0.01% | 896 |
|
|
2019
Q4 | $2.47M | Buy |
22,955
+8,721
| +61% | +$937K | 0.01% | 924 |
|
|
2019
Q3 | $1.28M | Sell |
14,234
-232
| -2% | -$20.9K | 0.01% | 1209 |
|
|
2019
Q2 | $1.22M | Sell |
14,466
-576
| -4% | -$48.6K | 0.01% | 1231 |
|
|
2019
Q1 | $1.33M | Buy |
15,042
+4,665
| +45% | +$411K | 0.01% | 1126 |
|
|
2018
Q4 | $741K | Sell |
10,377
-681
| -6% | -$48.6K | ﹤0.01% | 1382 |
|
|
2018
Q3 | $1.36M | Buy |
11,058
+8,989
| +434% | +$1.1M | 0.01% | 1130 |
|
|
2018
Q2 | $203K | Buy |
+2,069
| New | +$203K | ﹤0.01% | 2453 |
|